货号:A370752
同义名:
5-氟脲嘧啶
/ 5-FU; NSC 19893
5-Fluorouracil 是一种强效的抗肿瘤化合物,通过抑制胸苷酸合成酶,影响嘧啶的合成,从而耗竭细胞内 dTTP 库。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | DNA synthesis ↓ ↑ | helicase ↓ ↑ | RdRp ↓ ↑ | ribonucleotide reductase ↓ ↑ | tRNA synthetase ↓ ↑ | YB-1 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fexinidazole | ✔ | 98% | |||||||||||||||||
| Daptomycin | ✔ | 98% | |||||||||||||||||
| Blasticidin S·HCl | ✔ | 98% | |||||||||||||||||
| Metronidazole | ✔ | 98% | |||||||||||||||||
| Daunorubicin HCl |
+++
DNA synthesis, Ki: 20 nM |
98% | |||||||||||||||||
| Triglycidyl isocyanurate | ✔ | p53 | 98+% | ||||||||||||||||
| Nedaplatin | ✔ | 99%+ | |||||||||||||||||
| Oxolinic acid | ✔ | 98+% | |||||||||||||||||
| Bendamustine | ✔ | 98+% | |||||||||||||||||
| Trifluridine | ✔ | 98% | |||||||||||||||||
| Robinetin | ✔ | 99%+ | |||||||||||||||||
| Carboplatin | ✔ | 99% | |||||||||||||||||
| Cidofovir | ✔ | 99% | |||||||||||||||||
| Cisplatin | ✔ | 99% | |||||||||||||||||
| Cytarabine |
++++
DNA synthesis, IC50: 16 nM |
98% | |||||||||||||||||
| Acelarin |
++++
DNA synthesis, EC50: 0.2 nM |
99%+ | |||||||||||||||||
| Oxaliplatin | ✔ | 98% | |||||||||||||||||
| YK-4-279 | ✔ | 99%+ | |||||||||||||||||
| ML216 |
+
BLMfull-length, IC50: 2.98 μM BLM636-1298, IC50: 0.97 μM |
99%+ | |||||||||||||||||
| RK-33 | ✔ | 98% | |||||||||||||||||
| Brr2-IN-3 | ✔ | 99%+ | |||||||||||||||||
| Phen-DC3 Trifluoromethanesulfonate | ✔ | 95% | |||||||||||||||||
| Favipiravir | ✔ | 99% | |||||||||||||||||
| Suramin sodium salt |
++
RdRp, IC50: 0.26 μM |
99%+ | |||||||||||||||||
| Clofarabine |
++
Ribonucleotide reductase, IC50: 65 nM |
97% | |||||||||||||||||
| Didox | ✔ | 98% | |||||||||||||||||
| (E)-3-AP | ✔ | 99% | |||||||||||||||||
| Halofuginone |
+++
prolyl-tRNA synthetase, Ki: 18.3nM |
99%+ | |||||||||||||||||
| BC-LI-0186 |
+++
Leucyl-tRNA synthetase, IC50: 46.11 nM Leucyl-tRNA synthetase, Kd: 42.1 nM |
98% | |||||||||||||||||
| SU056 |
+
YB-1, IC50: 1.73 μM |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | 5-Fluorouracil (5-FU), or combined with other chemotherapeutic agents, is widely used in the treatment of a range of cancers, including colorectal and breast cancers, head and neck cancers, cancers of the aerodigestive tract[1]. 5-Fluorouracil can disrupt RNA synthesis through RNA mis-incorporation by its active metabolites, as well as block dTMP synthesis through inhibition of thymidylate synthase. After entering into cells, 5-Fluorouracil can be converted to its active metabolites, fluorodeoxyuridine monophosphate (FdUMP), fluorodeoxyuridine triphosphate (FdUTP) and fluorouridine triphosphate[2]. FdUMP can inhibit the thymidylate synthase through binding to the nucleotide-binding site of thymidylate synthase, thus blocking the binding of normal substrate dUMP and inhibiting dTMP synthesis. And this will cause the disruption of DNA replication and repair[3]. FUTP can extensively incorporate into RNA and disrupt RNA processing and function[4]. Thus, 5-Fluorouracil showed cytotoxicity in various cells. |
| 作用机制 | The mechanism of cytotoxicity of 5-FU has been ascribed to the mis-incorporation of fluoronucleotides into RNA and DNA, as well as the inhibition of thymidylate synthase[4]. |
| Concentration | Treated Time | Description | References | |
| WiDr cells | 0–115.2 μM | 48 hours | To test the effect of SQLE knockdown on 5-FU sensitivity, results showed that SQLE knockdown increased the sensitivity of tumor cells to 5-FU treatment. | Cell Commun Signal. 2024 May 18;22(1):278. |
| RKO cells | 0–115.2 μM | 48 hours | To test the effect of SQLE knockdown on 5-FU sensitivity, results showed that SQLE knockdown increased the sensitivity of tumor cells to 5-FU treatment. | Cell Commun Signal. 2024 May 18;22(1):278. |
| Hct116 cells | 20 ×10−6M | 24 hours | To evaluate the effect of 5-FU on Hct116 cell growth, showing remarkable dose-dependent growth inhibition. | Adv Sci (Weinh). 2022 Oct;9(30):e2200717. |
| Detroit562 | 0.5–50 µM | 72 h | To evaluate the resistance of CD10-positive subpopulation to 5-Fluorouracil, the results showed that the CD10-positive subpopulation was significantly more refractory to 5-Fluorouracil than the CD10-negative subpopulation. | Br J Cancer. 2014 Jul 29;111(3):506-14. |
| HUVECs | 1 µg/mL | 48 h | 5-FU was used as a functional inhibitor of endothelial cells, cocultured with PD-MSCs and WKYMVm to evaluate its effect on endothelial cell activity and angiogenesis. | Cells. 2022 Jan 11;11(2):232. |
| MCF-7 cells | 1, 2, 3, 4, 5, 6 µg/mL | 24 h | To detect the sensitivity of MCF-7 cells to 5-fluorouracil, the results showed that EVs-treated cells had reduced sensitivity to 5-fluorouracil and significantly increased IC50. | Cell Biosci. 2021 Apr 5;11(1):68. |
| Yeast cells (Saccharomyces cerevisiae) | 5 μg/ml | 5 h | To investigate the effect of 5-FU on tRNAValAAC stability in trm4 trm8 double mutants. Results showed that 5-FU significantly reduced tRNAValAAC levels even at 30°C, and this effect was suppressed in met22 or xrn1 mutants. | Nucleic Acids Res. 2024 Jun 10;52(10):5841-5851 |
| Yeast cells (Saccharomyces cerevisiae) | 10 μg/ml | 5 h | To investigate the effect of 5-FU on tRNAValAAC stability in yeast cells lacking specific tRNA methylations. Results showed that 5-FU significantly reduced tRNAValAAC levels in trm8 mutants, and this effect was suppressed in met22 or xrn1 mutants. | Nucleic Acids Res. 2024 Jun 10;52(10):5841-5851 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Wild-type, Hoxa9-deficient, and miR-155-deficient mice | Intraperitoneal injection | 150 mg/kg | Single injection, lasting 4 days | To study the function of HOXA9 in bone marrow cells | Nucleic Acids Res. 2010 Sep;38(16):5472-8 |
| Mice | APCmin/þ mouse model | Intravenous injection | 50 mg/kg | Once daily for 8 weeks | To evaluate the anti-tumor effect of 5-FU in APCmin/t mice, the results showed that 5-FU significantly reduced the number and size of adenomas. | Nat Commun. 2017 Jan 4;8:14058 |
| Mice | Primary myelofibrosis model | Intravenous injection | 150 mg/kg | Single injection | Used to pre-treat donor mice for bone marrow cell collection | Nat Cell Biol. 2017 Jun;19(6):677-688 |
| Mice | Chronic Myeloid Leukemia Model | 200 mg/kg | Single dose | To construct a chronic myeloid leukemia model for studying the role of RalA in leukemia. | Int J Biol Sci. 2023 Feb 13;19(4):1211-1227 |
| Dose | Mice (i.p.): min = 10 mg/kg[5], max = 200 mg/kg[6] | ||||||||||||||||||||
| Administration | i.p. | ||||||||||||||||||||
| Pharmacokinetics |
|
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
7.69mL 1.54mL 0.77mL |
38.44mL 7.69mL 3.84mL |
76.88mL 15.38mL 7.69mL |
|
| CAS号 | 51-21-8 |
| 分子式 | C4H3FN2O2 |
| 分子量 | 130.08 |
| SMILES Code | O=C(N1)NC=C(F)C1=O |
| MDL No. | MFCD00006018 |
| 别名 | 5-氟脲嘧啶 ;5-FU; NSC 19893 |
| 运输 | 蓝冰 |
| InChI Key | GHASVSINZRGABV-UHFFFAOYSA-N |
| Pubchem ID | 3385 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place,Inert atmosphere,2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(384.39 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 10 mg/mL(76.88 mM),配合低频超声,并水浴加热至45℃助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1